Strs Ohio Adaptive Biotechnologies Corp Transaction History

Strs Ohio

$25.5 Billion
Q3 2024

A detailed history of Strs Ohio transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Strs Ohio holds 91,700 shares of ADPT stock, worth $511,686. This represents 0.0% of its overall portfolio holdings.

Number of Shares

91,700

Previous 91,700 -0.0%

Holding current value

$511,686

Previous $331,000 41.69%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$2.34 - $3.96 $21,996 - $37,224	9,400 Added 11.42%	91,700 $331,000
Q1 2024 May 13, 2024	SELL	$2.88 - $4.8 $14,976 - $24,960	-5,200 Reduced 5.94%	82,300 $264,000
Q4 2023 Jan 30, 2024	BUY	$3.46 - $5.33 $13,148 - $20,254	3,800 Added 4.54%	87,500 $428,000
Q2 2023 Jul 31, 2023	BUY	$6.19 - $8.78 $16,713 - $23,706	2,700 Added 3.33%	83,700 $561,000
Q1 2023 Aug 02, 2023	SELL	$7.8 - $10.11 $21,060 - $27,297	-2,700 Reduced 3.23%	81,000 $715,000
Q4 2022 Jan 26, 2023	SELL	$6.26 - $9.34 $97,030 - $144,770	-15,500 Reduced 16.06%	81,000 $618,000
Q3 2022 Oct 27, 2022	BUY	$6.5 - $12.67 $16,900 - $32,942	2,600 Added 2.77%	96,500 $687,000
Q2 2022 Jul 25, 2022	BUY	$6.4 - $14.73 $600,960 - $1.38 Million	93,900 New	93,900 $759,000
Q2 2021 Jul 26, 2021	SELL	$32.22 - $44.59 $721,083 - $997,924	-22,380 Closed	0 $0
Q1 2021 Apr 23, 2021	BUY	$37.26 - $67.74 $274,270 - $498,634	7,361 Added 49.01%	22,380 $901,000
Q4 2020 Jan 25, 2021	SELL	$45.01 - $65.47 $154,339 - $224,496	-3,429 Reduced 18.59%	15,019 $888,000
Q3 2020 Dec 14, 2020	BUY	$35.79 - $48.81 $192,371 - $262,353	5,375 Added 41.12%	18,448 $897,000
Q2 2020 Jul 23, 2020	BUY	$24.95 - $48.38 $326,171 - $632,471	13,073 New	13,073 $632,000

Others Institutions Holding ADPT

# of Institutions

202

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $797M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account